4//SEC Filing
Oltmans Curtis Gale 4
Accession 0001193125-25-322740
CIK 0001680581other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:10 PM ET
Size
4.8 KB
Accession
0001193125-25-322740
Insider Transaction Report
Form 4
Oltmans Curtis Gale
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-12-15$12.92/sh−3,452$44,600→ 10,252 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.
- [F2]Includes 10,252 shares that were previously acquired under the Issuer's employee stock purchase plan.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001714982
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:10 PM ET
- Size
- 4.8 KB